Time Has Come For Outsourcing Clinical Data Management – DIA Japan
This article was originally published in PharmAsia News
TOKYO - To curb soaring worldwide research and development costs, pharmaceutical companies need to outsource "basically anything that can be pushed down the fiber optic cable," including clinical data management, Ron Fitzmartin, vice president, Informatics and Knowledge Management for New Jersey-based Daiichi Sankyo Pharma Development, told a Drug Information Association conference
You may also be interested in...
Following the growing trend of outsourcing primary operational functions, Eisai announced Feb. 13 a collaborative effort with Accenture to manage Eisai's Japan, U.S., and European Union clinical data from Accenture's Chennai, India-based delivery center
A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).